The Caledonian-Record

Dyno Therapeutics Launches Two New AAV Capsids and AI Platform for Rare Disease Therapeutic Development at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced the launch of two new ...
The Caledonian-Record

Dyno Therapeutics Announces Expanded Frontiers Network and Second Annual Genetic Agency Technology Conference (GATC)

The Frontiers Network and GATC both exist because getting transformative therapeutic options to patients is hard, and most developers can't do it without trusted partners. At Dyno we’ve established ...
Healio

Handheld dynamometer reliable and safe to assess lower limb strength during dialysis

Please provide your email address to receive an email when new articles are posted on . Results showed high to very high relative reliability among patients. Interrater reliability had wider value ...
Business Wire

Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to enable in vivo gene delivery, today announced that Roche (SIX: RO, ...